Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Clinical trial NCT07232030 · RECRUITING

Trial details

NCT number: NCT07232030
Sponsor: CVRx, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Heart Failure Heart Failure NYHA Class II Heart Failure NYHA Class III

Start date: 2026-04-24
Primary completion: 2033-01-01
Enrollment: 2500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.